Stable F&E Budgets help Biotech Suppliers Defy the Crisis

Weaknesses in product development and high research costs for pharmaceutical companies provide opportunities for biotech companies[more]

BioGenes as new designated partner in EU funded dementia project

Berlin, Germany, February 2, 2008 / b3c newswire / – BioGenes GmbH, a specialist in sophisticated antibody development, has been chosen as a new partner of cNEUPRO. cNEUPRO is a EU funded research project to analyse...[more]